71 related articles for article (PubMed ID: 31856446)
1. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
[No Abstract] [Full Text] [Related]
2. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
Logan BR; Fu D; Howard A; Fei M; Kou J; Little MR; Adom D; Mohamed FA; Blazar BR; Gafken PR; Paczesny S
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37526081
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in chronic graft-versus-host disease.
Rozmus J; Schultz KR
Expert Rev Hematol; 2011 Jun; 4(3):329-42. PubMed ID: 21668397
[TBL] [Abstract][Full Text] [Related]
4. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
Crossland RE; Perutelli F; Bogunia-Kubik K; Mooney N; Milutin Gašperov N; Pučić-Baković M; Greinix H; Weber D; Holler E; Pulanić D; Wolff D; Dickinson AM; Inngjerdingen M; Grce M
Front Immunol; 2020; 11():602547. PubMed ID: 33424849
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Cuvelier GDE; Ng B; Abdossamadi S; Nemecek ER; Melton A; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Ostroumov E; Schultz KR
Blood Adv; 2023 Jul; 7(14):3612-3623. PubMed ID: 36219586
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkers.
Avni B; Neiman D; Shaked E; Gal-Rosenberg O; Grisariu S; Kuzli M; Avni I; Fracchia A; Stepensky P; Zuckerman T; Lev-Sagie A; Fox-Fisher I; Piyanzin S; Moss J; Salpeter SJ; Glaser B; Shemer R; Dor Y
J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 37971879
[TBL] [Abstract][Full Text] [Related]
7. Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA.
Pang Y; Andargie TE; Jang MK; Kong H; Park W; Hill T; Redekar N; Fu YP; Parth DA; Holtzman NG; Pavletic SZ; Agbor-Enoh S
iScience; 2023 Nov; 26(11):108160. PubMed ID: 38026221
[TBL] [Abstract][Full Text] [Related]
8. Crowdsourcing Skin Demarcations of Chronic Graft-Versus-Host Disease in Patient Photographs: Training Versus Performance Study.
McNeil AJ; Parks K; Liu X; Jiang B; Coco J; McCool K; Fabbri D; Duhaime EP; Dawant BM; Tkaczyk ER
JMIR Dermatol; 2023 Dec; 6():e48589. PubMed ID: 38147369
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Wu H; Shi J; Luo Y; Tan Y; Zhang M; Lai X; Yu J; Liu L; Fu H; Huang H; Zhao Y
JAMA Netw Open; 2021 Jan; 4(1):e2034750. PubMed ID: 33502484
[TBL] [Abstract][Full Text] [Related]
10. The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside.
Feng Y; Chen X; Cassady K; Zou Z; Yang S; Wang Z; Zhang X
Front Oncol; 2020; 10():611690. PubMed ID: 33489922
[TBL] [Abstract][Full Text] [Related]
11. [The clinical observation of sirolimus combined with calcineurin inhibitors for steroid-resistant/steroid-dependent extensive cGVHD].
Zhu W; Feng YM; Chen T; Yao H; Quan Y; Rao J; Gao L; Zhang C; Liu Y; Gao L; Kong PY; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):716-722. PubMed ID: 33113602
[No Abstract] [Full Text] [Related]
12. Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
Chang YJ; Wu DP; Lai YR; Liu QF; Sun YQ; Hu J; Hu Y; Zhou JF; Li J; Wang SQ; Li W; Du X; Lin DJ; Ren HY; Chen FP; Li YH; Zhang X; Huang H; Song YP; Jiang M; Hu JD; Liang YM; Wang JB; Xiao Y; Huang XJ
J Clin Oncol; 2020 Oct; 38(29):3367-3376. PubMed ID: 32650683
[TBL] [Abstract][Full Text] [Related]
13. [Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].
;
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):265-275. PubMed ID: 33979969
[No Abstract] [Full Text] [Related]
14. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
[No Abstract] [Full Text] [Related]
15. [The Expression and Significance of Serum Protein ROCK2 in Patients with Chronic Graft-Versus-Host Disease].
Tang P; Zheng CH; Dong ZK; Xie MH; Xie XS; Sun H; Sun L; Wan DM; Liu YF; Jiang ZX; Guo R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1606-1609. PubMed ID: 34627448
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of serum free light chain level early after allogeneic hematopoietic stem cell transplantation for chronic graft-versus-host disease, a preliminary study.
Wang B; Liang Z; Liu W; Sun Y; Cen X; Dong Y; Ren H
Clin Transplant; 2020 Jul; 34(7):e13865. PubMed ID: 32242991
[TBL] [Abstract][Full Text] [Related]
17. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
[TBL] [Abstract][Full Text] [Related]
18. Recent advances and research progress in biomarkers for chronic graft versus host disease.
Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
